Apidel's Unattributed Round

Apidel raised a round of funding on February 02, 2017.

Apidel is developing and formulating new pharmaceutical products based on its ApidSOLTM and ApidCORTM proprietary drug delivery technologies. The technologies enable effective drugs to be formulated i…

Articles about Apidel's Unattributed Round: